These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 870336)

  • 41. The effect of nialamide, pargyline and tranylcypromine on the removal of amphetamine by the perfused liver.
    Trinker FR; Rand MJ
    J Pharm Pharmacol; 1970 Jul; 22(7):496-9. PubMed ID: 4395053
    [No Abstract]   [Full Text] [Related]  

  • 42. Distribution and metabolism of tryptamine in rat brain.
    Wu PH; Boulton AA
    Can J Biochem; 1973 Jul; 51(7):1104-12. PubMed ID: 4725358
    [No Abstract]   [Full Text] [Related]  

  • 43. The effects of monoamine oxidase inhibitors on spinal synaptic activity.
    Anderson EG; Baker RG; Banna NR
    J Pharmacol Exp Ther; 1967 Dec; 158(3):405-15. PubMed ID: 5299660
    [No Abstract]   [Full Text] [Related]  

  • 44. Monoamine oxidase inhibition and recovery in the mouse brain at various ages after birth.
    Samsa JM; Baker PC; Hoff KM
    Biol Neonate; 1979; 35(5-6):249-54. PubMed ID: 476197
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR; Youdim MB
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of low- and high-dose tranylcypromine on [3H]tryptamine binding sites in the rat hippocampus and striatum.
    Goodnough DB; Baker GB; Mousseau DD; Greenshaw AJ; Dewhurst WG
    Neurochem Res; 1994 Jan; 19(1):5-8. PubMed ID: 8139763
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Inhibition of monoamine oxidase A and B in the heart and brain of the rat with amitriptyline, pargyline and pirlindol].
    Schraven E; Reibert R
    Arzneimittelforschung; 1984; 34(10):1258-60. PubMed ID: 6542783
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
    Grahame-Smith DG; Green AR
    Br J Pharmacol; 1974 Sep; 52(1):19-26. PubMed ID: 4281339
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of zimelidine and amitriptyline on the brain concentration of some indolic and phenolic monoamines in the mouse.
    Juorio AV; Boulton AA
    Eur J Pharmacol; 1984 Jan; 97(3-4):191-6. PubMed ID: 6200338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of amezinium on the release and catabolism of 3H-monoamines in brain slices.
    Steppeler A; Döring C; Hedler L; Starke K
    Biochem Pharmacol; 1982 Jul; 31(14):2395-402. PubMed ID: 7126251
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of 2,3-dioxoindoline on a behavioral syndrome after tryptamine in pargyline-treated mice.
    Kästner I; Müller M
    Pharmazie; 1981 Oct; 36(10):711. PubMed ID: 7312929
    [No Abstract]   [Full Text] [Related]  

  • 52. Inhibition of phenylethylamine metabolism in vivo-Effect of antidepressants.
    Von Voigtlander PF; Losey EG
    Biochem Pharmacol; 1976 Jan; 25(2):217-8. PubMed ID: 1259787
    [No Abstract]   [Full Text] [Related]  

  • 53. Biochemical correlates of behavior in schizophrenic patients. Schizophrenic patients receiving tryptophan and methionine or methionine together with a monoamine oxidase inhibitor.
    Berlet HH; Matsumoto K; Pscheidt GR; Spaide J; Bull C; Himwich HE
    Arch Gen Psychiatry; 1965 Dec; 13(6):521-31. PubMed ID: 5841751
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of tryptamine on the behavior of mice.
    Sugimoto Y; Yamada J; Horisaka K
    J Pharmacobiodyn; 1986 Jan; 9(1):68-73. PubMed ID: 2940357
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple forms of monoamine oxidase. Comparison of in vitro and in vivo inhibition patterns.
    Collins GG; Youdim MB; Sandler M
    Biochem Pharmacol; 1972 Jul; 21(14):1995-8. PubMed ID: 4405452
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of L-DOPA on the synthesis and excretion of tyramine.
    Boulton AA; Wu PH
    Adv Neurol; 1974; 5():119-25. PubMed ID: 4613157
    [No Abstract]   [Full Text] [Related]  

  • 57. Formation and release of 3H-tryptamine from 3H-tryptophan in rat spinal cord slices.
    Snodgrass SR; Iversen LL
    Adv Biochem Psychopharmacol; 1974; 10():141-50. PubMed ID: 4211048
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of chronic administration of drugs which modify neurotransmitter re-uptake, storage and turnover on levels of tyrosine and tryptophan hydroxylase in rat brain.
    Hulme EC; Hill R; North M; Kibby MR
    Biochem Pharmacol; 1974 May; 23(9):1393-404. PubMed ID: 4151580
    [No Abstract]   [Full Text] [Related]  

  • 59. Origin of urinary tyramine and tryptamine.
    DeQuattro VL; Sjoerdsma A
    Clin Chim Acta; 1967 May; 16(2):227-33. PubMed ID: 6033514
    [No Abstract]   [Full Text] [Related]  

  • 60. Human brain monoamine oxidase: multiple forms and selective inhibitors.
    Youdim MB; Collins GG; Sandler M; Bevan Jones AB; Pare CM; Nicholson WJ
    Nature; 1972 Mar; 236(5344):225-8. PubMed ID: 4553640
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.